How many patents does
Ambrx have?
patents
923
families
79
granted
238
applications
685
US
170
EP
108
CN
91
WO
48
JP
33
KR
31
RoW
442
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Ambrx
Top ten assignees appearing on patents
2009 - 2018
| ambrx | 846 |
| eli lilly & company | 81 |
| merck & company | 9 |
| elanco us | 6 |
| pfizer | 1 |
| abrx | 1 |
| sanofi pasteur | 1 |
2009
| ambrx | 85 |
2018
| ambrx | 48 |
| elanco us | 5 |
| eli lilly & company | 4 |
| merck & company | 2 |
Ambrx
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| methods for expression and purification of recombinant human growth hormone | 44 | 2004 |
| compositions containing, methods involving, and uses of non-natural amino acids and poly… 🛈 | 44 | 2004 |
| modified animal erythropoietin polypeptides and their uses | 40 | 2008 |
| modified fgf-21 polypeptides and their uses | 39 | 2007 |
| non-natural amino acid replication-dependent microorganisms and vaccines | 38 | 2008 |
| modified relaxin polypeptides and their uses | 37 | 2010 |
| modified bovine g-csf polypeptides and their uses | 36 | 2008 |
| compositions containing, methods involving, and uses of non-natural amino acid linked do… 🛈 | 33 | 2011 |
| modified human plasma polypeptide or fc scaffolds and their uses | 29 | 2006 |
| compositions of aminoacyl-trna synthetase and uses thereof | 26 | 2004 |